Klimek, Ludger
Brehler, Randolf
Bergmann, Karl-Christian
Casper, Ingrid
Klimek, Felix
Hagemann, Jan
Polk, Marie-Luise
Cuevas, Mandy
Funding for this research was provided by:
Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
Article History
Received: 15 November 2022
Accepted: 13 December 2022
First Online: 23 January 2023
Conflict of interest
: L. Klimek reports grants and/or honoraria from Allergopharma, MEDA/Mylan, HAL Allergie, ALK Abelló, ALLERGIKA, LETI Pharma, Stallergenes, Quintiles, Sanofi, grants from ASIT Biotech, Lofarma, Allergy Therapeutics, AstraZeneca, GSK, Inmunotek, Cassella med, outside the submitted work; and memberships with: AeDA, DGHNO, German Academy of Allergology and Clinical Immunology, ENT-BV, GPA and EAACI. L. Klimek is editor in chief of <i>Allergo Journal International</i>. R. Brehler reports honoraria from ALK, Allergopharma, Bencard, HAL, Leti, Stallergenes, Astra Zeneca, GSK, MedUpdate, Novertis, BiotechTools, Genentech and Circassia, outside the submitted work. K.‑C. Bergmann received honoraria from Allergopharma, HAL Allergie, ALK Abelló, LETI Pharma, Stallergenes, Sanofi, Lofarma, Novartis, Bencard Allergy Therapeutics, AstraZeneca and GSK, outside the submitted work. I. Casper, F. Klimek, J. Hagemann, M.-L. Polk and M. Cuevas declare that they have no competing interests.